Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/17/2007EP1843765A2 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
10/17/2007EP1843764A2 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
10/17/2007EP1843763A2 Compounds and compositions as ppar modulators
10/17/2007EP1843762A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
10/17/2007EP1843761A1 Extended release formulation of levetiracetam
10/17/2007EP1843760A1 Classes of compounds that interact with integrins
10/17/2007EP1843758A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
10/17/2007EP1843757A1 Phantom phenomena treatment
10/17/2007EP1843750A1 Nebulizer formulation
10/17/2007EP1843744A2 Stable prostaglandin-containing compositions
10/17/2007EP1843661A2 Compositions comprising o-acetylsalicyl derivatives of aminocarbohydrates and amino acids
10/17/2007EP1755623A4 Treatment of lung diseases and pre-lung disease conditions
10/17/2007EP1699398A4 Enhancement of immune responses
10/17/2007EP1648871B1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity
10/17/2007EP1648564B1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
10/17/2007EP1646393A4 A stable clozapine suspension formulation
10/17/2007EP1608349B1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
10/17/2007EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/17/2007EP1565438B1 Antitumor benzoylsulfonamides
10/17/2007EP1546216B1 Methods of drug delivery using sulphated chitinous polymers
10/17/2007EP1531684B1 Method for controlling hairballs
10/17/2007EP1492540B1 The use of devazepide as analgesic agent
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1446413A4 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines
10/17/2007EP1434991B1 New potent, selective and non toxic c-kit inhibitors
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1420771B9 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases
10/17/2007EP1416916B1 Chitin microparticles and their medical uses
10/17/2007EP1414315B9 Complex antioxidant preparation
10/17/2007EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007EP1392713B1 Liver x receptor agonists
10/17/2007EP1372638A4 Functional role for cannabinoids in autonomic stability during sleep
10/17/2007EP1347745A4 Dietary composition containing conjugated linoleic acid and calcium for improved health
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007EP1315505B1 Pharmaceutical compositions for headache, migraine, nausea and emesis
10/17/2007EP1313717B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
10/17/2007EP1311289B1 Vaccines containing ribavirin
10/17/2007EP1267848B1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer
10/17/2007EP1225882B1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
10/17/2007EP1218353B1 Quinazoline derivatives
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007EP1173432B1 Piperidine-indole compounds having 5-ht6 affinity
10/17/2007EP1158990B1 Use of e5564 for the treatment of sepsis by intravenous infusion
10/17/2007EP1153034B1 Growth hormone secretagogues
10/17/2007EP1102758B1 Particle-forming compositions containing fused pyrrolocarbazoles
10/17/2007EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/17/2007EP1062871B1 Bactericides
10/17/2007EP0970195B1 Fatty-acid amide hydrolase
10/17/2007EP0787122B9 Calcium receptor-active compounds
10/17/2007CN101056990A Polymorphisms in the epidermal growth factor receptor gene promoter
10/17/2007CN101056981A Method for down-regulating gene expression in fungi
10/17/2007CN101056880A 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc
10/17/2007CN101056879A Purine derivatives as A3 and A1 adenosine receptor agonists
10/17/2007CN101056878A Azaindole carboxamides
10/17/2007CN101056877A Imidazoquinoline compounds
10/17/2007CN101056876A Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
10/17/2007CN101056875A Substituted phenylaminothiazoles and use thereof
10/17/2007CN101056872A Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
10/17/2007CN101056871A Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/17/2007CN101056868A Substituted chroman derivatives, medicaments and use in therapy
10/17/2007CN101056867A Process for production of optically active amine derivatives
10/17/2007CN101056866A 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
10/17/2007CN101056865A Aminoquinazolines compounds
10/17/2007CN101056862A Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
10/17/2007CN101056861A Carbamoyl-substituted spiro derivative
10/17/2007CN101056859A Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand
10/17/2007CN101056856A Method for preparing torsemide crystal with pure state
10/17/2007CN101056855A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
10/17/2007CN101056851A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/17/2007CN101056850A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/17/2007CN101056846A Diphenylethylene compounds and uses thereof
10/17/2007CN101056673A Hydrochloride of 4-((4-(4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile
10/17/2007CN101056672A Process for {3-[2(R)-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl]ethoxy]-3(S)-(4-fluorophenyl) morpholin-4-yl}-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid
10/17/2007CN101056662A Adhesion preventive material and method of preventing adhesion
10/17/2007CN101056657A Antiviral composition
10/17/2007CN101056644A Oral composition containing difructose anhydride
10/17/2007CN101056643A Long acting injectable crystal formulations of estradiol metabolites and methods of using same
10/17/2007CN101056642A Improved photosensitizer formulations and their use
10/17/2007CN101056641A S-mirtazapine for the treatment of hot flush
10/17/2007CN101056640A Aerosol formulation for the inhalation of beta-agonists
10/17/2007CN101056639A 噻唑并吡啶激酶抑制剂 Thiazolopyridine kinase inhibitors
10/17/2007CN101056638A Treatment of mastitis with enrofloxacin
10/17/2007CN101056637A Pharmaceutical composition for transdermal administration of perospirone
10/17/2007CN101056636A Aqueous ophthalmic suspension of crystalline rebamipide
10/17/2007CN101056635A Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/17/2007CN101056634A Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
10/17/2007CN101056633A Pi3 kinase gamma inhibitors for the treatment of anaemia
10/17/2007CN101056632A Compounds and compositions as protein kinase inhibitors
10/17/2007CN101056631A Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
10/17/2007CN101056630A Vitamin e for facilitating the synchronization of circadian rhythm
10/17/2007CN101056629A Use of 2-phenyl-1,2-ethanediol-(di)carbamates for treating epileptogenesis and epilepsy
10/17/2007CN101056628A Ester derivatives and medicinal use thereof
10/17/2007CN101056627A Therapeutic agent for interstitial cystitis
10/17/2007CN101056626A Treatment of acne using derivatives of 5-aminolevulinic acid
10/17/2007CN101056623A Stabilized freeze-dried formulation for cephalosporin derivatives
10/17/2007CN101056622A A process for preparing formulations of lipophilic active substances by spray freeze drying
10/17/2007CN101056621A Treatment of androgen-deprivation induced osteoporosis
10/17/2007CN101056619A Pharmaceutical compositions comprising a camtothecin derivate
10/17/2007CN101056613A Controlled and directed local delivery of anti-inflammatory compositions
1 ... 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 ... 7860